Skip to main content
Home

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Crucell
- Credit: Crucell in Leiden. Source:Wikimedia Commons/ Bic
Health
America
anti-ebola vaccine
Atlanta
Biotech company
Canadian
Crucell
development
ebola
experimental cures
FDA
Georgia
Guinea
Leiden
Maria Pau
medication
medicine
Nigeria
outbreak
positive results
pre-clinical phase
Sierra Leone
spread
testing
TKM-Ebola
vaccine
West Africa
ZMapp
Friday, 8 August 2014 - 10:57
Share this:
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • reddit

Ebola vaccine developed in NL

A bio-tech company in Leiden, Crucell, is making headway developing a vaccine against the deadly, and fast-spreading ebola virus. In an interview with Het Financieele Dagblad, Maria Pau, head of the research program, says that data from tests on monkeys is very promising. The virus that broke out in Guinea in March has killed almost 1000 people, leaving more than 700 still infected. In 50 to 90 percent of the cases, the virus is fatal. The race is on to develop a vaccine that can stem the spread of the virus, which has been recorded in Liberia, Sierra Leone and Nigeria so far. Pau expects that the vaccine will be ready to be tested on humans at the end of 2015 or beginning of 2016. The development of the vaccine is currently in a pre-clinical phase. The American Ministry for Public Health currently has approved an experimental form of a medicine called TKM-Ebola. According to the Canadian fabricator, the medicine helps to block the ebola virus. The fabricator said that the Food and Drug Administrator (FDA) 'verbally' agreed to remove restrictions that were standing in the way of further research and availability of the medicine. An earlier testing phase of the medicine on humans was stopped, which the fabricators of the medicine, Tekmira Pharmaceuticals may resume now that the restrictions have been lifted by the FDA. According to the pharmaceuticals company, earlier tests on healthy people were stopped by the FDA due to questions about side-effects such as nausea and low blood pressure. Two Americans who became infected by the virus in West Africa are currently being treated in Atlanta with another experimental medicine called ZMapp, which is manufactured from antibodies made by test animals. Both ZMapp and TKM-Ebola are supposed to boost the immune system as the body fights the ebola virus.

Follow us:

Latest stories

  • Dutch universities raise concerns over Cabinet's plan to reduce English instruction
  • Dutch father and son killed in car crash in Thailand; Third Dutchman injured
  • Schiphol pushes €3 billion into catching up on maintenance
  • Dutch government sites easy to spoof because they don't end in .gov or .overheid
  • Suspect in Rotterdam killings arraigned Wednesday; Was to be evicted before shootings
  • Omtzigt’s NSC party chair resigns after prior labor dispute surfaces

Top stories

  • Suspect in Rotterdam killings arraigned Wednesday; Was to be evicted before shootings
  • Gov't to compensate 3,000 families around Schiphol for noise pollution
  • Gender wage gap increases to 7.4% in Netherlands
  • Amsterdam preparing to lower speed limit to 30 kilometers per hour
  • Over €100,000 raised for Rotterdam shooting victims
  • RKC goalkeeper Etienne Vaessen regains consciousness after on-field collapse

© 2012-2023, NL Times, All rights reserved.

Footer menu

  • Privacy
  • Contact
  • Partner content